Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.
about
Combination of three-dimensional conformal radiotherapy and transcatheter arterial chemoembolisation versus transcatheter arterial chemoembolisation for primary hepatocellular carcinomaAntioxidative dietary compounds modulate gene expression associated with apoptosis, DNA repair, inhibition of cell proliferation and migrationAdenovirus-mediated CD40L gene therapy induced both humoral and cellular immunity against rat model of hepatocellular carcinomaControlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs.Prevention of hepatocellular carcinoma in nonviral-related liver diseases.MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.DEC1 nuclear expression: a marker of differentiation grade in hepatocellular carcinomaEpidemiology of hepatitis C: related hepatocellular carcinoma in CameroonGlypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathwayFamily history of hepatocellulcar carcinoma is not associated with its patients' prognosis after hepatectomy.Low-dose chemotherapy of hepatocellular carcinoma through triggered-release from bilayer-decorated magnetoliposomes.Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.Sorafenib in liver cancer.RPL36 as a prognostic marker in hepatocellular carcinoma.Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.Proteomic identification of molecular targets of gambogic acid: role of stathmin in hepatocellular carcinoma.Chemoembolization of intermediate stage hepatocellular carcinomas: results from a Nordic tertiary liver cancer center.Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma.MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study.Postoperative outcomes of patients with hepatocellular carcinoma negative for all virus-related markers.Two-dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma.Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10.Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience.The significance of Exonuclease 1 K589E polymorphism on hepatocellular carcinoma susceptibility in the Turkish population: a case-control study.SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro.The Diagnostic Performance of Liver MRI without Intravenous Contrast for Detecting Hepatocellular Carcinoma: A Case-Controlled Feasibility Study.
P2860
Q26471711-6E05147E-C359-417D-8166-B6FC91594CD7Q27027482-A4F59A38-3DBB-4A97-BF97-D247D929B896Q28572729-F50862E1-1E6F-4FE9-A5AF-29A26C197256Q30226462-5258CDBA-A870-4FA9-815F-419DB7226100Q30379438-5CF4063D-D832-4BA5-B849-0E41631837C8Q33555339-628A67F3-C562-4960-8292-656277229521Q34863421-E8EF6F68-EAEF-45D8-8239-055478ACC866Q35593576-47CCE941-58BE-4732-BD6F-6953AEA2982CQ36818088-824AECD4-67EB-4B99-A2E9-957003555446Q37367449-EB06AFBD-191E-4697-9D98-ADA04E4B0422Q37716938-464BDFDC-A172-4F12-BDFD-65533F6C05F6Q37764965-1C810B82-8830-47B9-A6A5-BD42EE2AE837Q38004078-0B095235-95F6-464D-9CAB-37F5BD621BDBQ39452282-DEC337B7-01DA-4D37-9431-EAC2E5F4B1A1Q39465544-788F824A-F125-4D5B-88D1-DEF3E07C8066Q39904664-A48B0DC8-17DD-45E7-B74A-FA06F4A825DDQ40226035-F7A1C94B-B9B3-427A-AFCC-DCECDF82EA40Q41601067-C88039FD-D068-4685-8283-18AB715277C8Q43257019-138A9FCB-3712-49D4-AE7E-2762B0D322D7Q43273754-69BC3333-11E7-4996-852F-15EF77CB3440Q44503949-2DD9E0C6-3769-46BB-BB7F-570A32E64766Q46693261-09C69487-B186-4B6E-8C0F-9FFF4E204861Q47119441-99FF5B50-48D0-449B-922F-4A6689BF039DQ49151614-BB566F3F-ED73-41F5-B34D-BDA2F77D13A7Q53195871-012DFF44-6BB1-4338-A337-00D49678A0D7Q53299871-679CECE5-663D-456B-B994-3CAD90B039C5Q55424498-D5B31A81-E700-4795-8350-01CE4E45FEC2
P2860
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Hepatocellular carcinoma preve ...... traints of developing nations.
@ast
Hepatocellular carcinoma preve ...... traints of developing nations.
@en
type
label
Hepatocellular carcinoma preve ...... traints of developing nations.
@ast
Hepatocellular carcinoma preve ...... traints of developing nations.
@en
prefLabel
Hepatocellular carcinoma preve ...... traints of developing nations.
@ast
Hepatocellular carcinoma preve ...... traints of developing nations.
@en
P2093
P2860
P356
P1476
Hepatocellular carcinoma preve ...... traints of developing nations.
@en
P2093
Antonio Colecchia
Davide Festi
Enrico Roda
Francesca Lodato
Francesco Azzaroli
Giuseppe Mazzella
P2860
P304
P356
10.3748/WJG.V12.I45.7239
P407
P577
2006-12-01T00:00:00Z